Fondazione Istituto Neurologico Nazionale Casimiro Mondino, IRCCS

Pavia 27100

5 studies enrolling now · 10 studies all time

What they study most

CIDP, CIDP - Chronic Inflammatory Demyelinating Polyneuropathy, Chronic Inflammatory Demyelinating Polyneuropathy, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Developmental and Epileptic Encephalopathy, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Irritability Associated With Autism Spectrum Disorder, Medication Overuse Headache, Migraine, Narcolepsy

Studies at this site

• A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP — Recruiting now
• A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP — Recruiting now
• A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine — Recruiting now
• A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy — Recruiting now
• A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE) — Enrolling by invitation
• A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache — Completed
• Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum Disorder — Stopped early
• Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum Disorder — Completed
• A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years — Completed
• A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures — Completed